Investment adviser · CRD 157698

AISLING CAPITAL LLC

Exempt reporting adviser (ERA)

Exempt reporting advisers use a shorter Form ADV report. Some adviser-level figures are not reported; fund disclosures appear below when available.

NEW YORK, NY, United States · Form ADV filed Mar 27, 2026

Adviser-level assets, account counts and staffing figures are unavailable in this filing. View the reported fund disclosures below →

Private funds & service providers

3 Private funds

The count excludes feeder funds. Funds in the latest filing appear first, ordered by reported gross assets. Earlier funds retain their last reported values.

AISLING CAPITAL II, LPVenture Capital Fund · Last reported Mar 27, 2026$53.4MGross asset value
Fund administrator J.P. MORGAN PRIVATE EQUITY FUND SERVICES BROOKLYN, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor COHNREZNICK LLP NEW YORK, New York, United States
Custodian BTIG, LLC SAN FRANCISCO, California, United States Related to adviser: No
Custodian CHARLES SCHWAB & CO., INC. SAN FRANCISCO, California, United States Related to adviser: No
Custodian CONTINENTAL STOCK TRANSFER & TRUST NEW YORK, New York, United States Related to adviser: No
Custodian HSBC BANK USA NA NEW YORK, New York, United States Related to adviser: No
Custodian MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED NEW YORK, New York, United States Related to adviser: No
Custodian SILICON VALLEY BANK SANTA CLARA, California, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

COHNREZNICK LLP
PCAOB 596

BTIG, LLC
SEC 8-65473

CHARLES SCHWAB & CO., INC.
SEC 8-16514

HSBC BANK USA NA
LEI 1IE8VN30JCEQV1H4R804

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
SEC 8-7221

SILICON VALLEY BANK
LEI 0K2D5AK28E3O5CC06E35

Fund details & source
Fund ID
805-1975228957
Reported beneficial owners
73
Minimum commitment
$5M
Form D file number
021-85483

Form ADV 2078184 · Mar 27, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

AISLING CAPITAL III, LPVenture Capital Fund · Last reported Mar 27, 2026$10.1MGross asset value
Fund administrator J.P. MORGAN PRIVATE EQUITY FUND SERVICES BROOKLYN, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor COHNREZNICK LLP NEW YORK, New York, United States
Custodian BTIG, LLC SAN FRANCISCO, California, United States Related to adviser: No
Custodian CHARLES SCHWAB & CO., INC. SAN FRANCISCO, California, United States Related to adviser: No
Custodian HSBC BANK USA NA NEW YORK, New York, United States Related to adviser: No
Custodian MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED NEW YORK, New York, United States Related to adviser: No
Custodian SILICON VALLEY BANK SANTA CLARA, California, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

COHNREZNICK LLP
PCAOB 596

BTIG, LLC
SEC 8-65473

CHARLES SCHWAB & CO., INC.
SEC 8-16514

HSBC BANK USA NA
LEI 1IE8VN30JCEQV1H4R804

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
SEC 8-7221

SILICON VALLEY BANK
LEI 0K2D5AK28E3O5CC06E35

Fund details & source
Fund ID
805-1158854406
Reported beneficial owners
63
Minimum commitment
$5M
Form D file number
021-122318

Form ADV 2078184 · Mar 27, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LPVenture Capital Fund · Last reported Mar 26, 2015$30MGross asset value

Feeder funds

  • PERSEUS-SOROS BIOPHARMACEUTICAL FUND INVESTOR, LTD.
  • PERSEUS-SOROS BIOPHARMACEUTICAL INVESTORS, LP
Fund administrator SS&C, INC. NEW YORK, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor COHNREZNICK LLP NEW YORK, New York, United States
Custodian AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC CHARLOTTE, North Carolina, United States Related to adviser: No
Custodian HSBC BANK USA NA NEW YORK, New York, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No
Fund details & source
Fund ID
805-5703280361
Reported beneficial owners
16
Minimum commitment
$10M
Form D file number
021-1111408

Form ADV 878422 · Mar 26, 2015 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Services & filing details

Most recent filing: Mar 27, 2026. View historical filings

Reported services

Not reported in these imported fields

Compensation

Not reported in these imported fields

Principal office

489 FIFTH AVENUE, 10TH FLOOR
NEW YORK, NY, 10017, United States

CRD 157698

Filing source

Form ADV 2078184 · Mar 27, 2026 · Items 1 & 5

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.